Impact of metabolic heterogeneity on tumor growth, invasion, and treatment outcomes

Cancer Research

Volumn 75, Issue 8, 2015, Pages 1567-1579

  Robertson Tessi, Mark ^a   Gillies, Robert J ^a   Gatenby, Robert A ^a   Anderson, Alexander R A ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; ANTINEOPLASTIC AGENT;

ARTICLE; CANCER CELL LINE; CANCER GROWTH; CELL METABOLISM; CYTOTOXICITY; DISEASE ASSOCIATION; GLYCOLYSIS; MATHEMATICAL MODEL; METABOLIC ACIDOSIS; PHENOTYPE; PRIORITY JOURNAL; SIMULATION; TREATMENT RESPONSE; TUMOR INVASION; TUMOR MICROENVIRONMENT; TURNOVER TIME; CELL PROLIFERATION; DRUG RESISTANCE; GENETIC HETEROGENEITY; GENETICS; HUMAN; METABOLISM; NEOPLASMS; PATHOLOGY; PH; TREATMENT OUTCOME;

ANGIOGENESIS INHIBITORS; CELL PROLIFERATION; DRUG RESISTANCE, NEOPLASM; GENETIC HETEROGENEITY; GLYCOLYSIS; HUMANS; HYDROGEN-ION CONCENTRATION; METABOLIC NETWORKS AND PATHWAYS; NEOPLASM INVASIVENESS; NEOPLASMS; TREATMENT OUTCOME;

EID: 84926655652     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-14-1428     Document Type: Article

References (50)

1. Dowling MR, Kan A, Heinzel S., Zhou JH, Marchingo JM, Wellard CJ, et al Stretched cell cycle model for proliferating lymphocytes. Proc Natl Acad Sci USA 2014; 111: 6377-82.
2. Smallbone K, Gatenby R, Gillies R., Maini P, Gavaghan D. Metabolic changes during carcinogenesis: potential impact on invasiveness. J Theor Biol 2007; 244: 703-13.
3. Macklin P, Edgerton ME, Thompson A.M., Cristini V. Patient-calibrated agent-based modelling of ductal carcinoma in situ (DCIS): from microscopic measurements to macroscopic predictions of clinical progression. J Theor Biol 2012; 301: 122-40.
4. EstrellaV, ChenT, Lloyd M, Wojtkowiak J., Cornnell HH, Ibrahim-Hashim A, et al. Acidity generated by the tumor micro environment drives local invasion. Cancer Res 2013; 73: 1524-35.
5. Wojtkowiak JW, Rothberg JM, Kumar V, Schramm K.J., Haller E., Proemsey JB, et al. Chronic autophagy is a cellular adaptation to tumor acidic pH microenvironments. Cancer Res 2012; 72: 3938-47.
6. Araujo R, McElwain D. The role of mechanical host-tumour interactions in the collapse of tumour blood vessels and tumour growth dynamics. J Theor Biol 2006; 238: 817-27.
7. Patan S, Munn L, Jain R. Intussusceptive microvascular growth in a human colon adenocarcinoma xenograft: a novel mechanism of tumor angiogenesis. Microvasc Res 1996; 51: 260-72.
8. Jain R. Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 2005; 307: 58-62.
9. Gerlinger M, Rowan AJ, Horswell S, Larkin J., Endesfelder D, Gronroos E, et al Intratumor heterogeneity and branched evolution revealed by multi-region sequencing. New Engl J Med 2012; 366: 883-92.
10. Gerlee P, Anderson AR Modelling evolutionary cell behaviour using neural networks: application to tumour growth. Biosystems 2009; 95: 166-74.
11. Pienta KJ, McGregor N, Axelrod R., Axelrod DE. Ecological therapy for cancer: defining tumors using an ecosystem paradigm suggests new opportunities for novel cancer treatments. Transl Oncol 2008; 1: 158.
12. Basanta D, Anderson ARA. Exploiting ecological principles to better understand cancer progression and treatment. Interface Focus 2013; 3: 200020.
13. Greaves M, Maley CC Clonal evolution in cancer. Nature 2012; 481: 306-13.
14. Lawrence MS, Stojanov P, Polak P., Kryukov GV, Cibulskis K, Sivachenko A, et al Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature 2013; 499: 214-8.
15. Sottoriva A, Spiteri I, Piccirillo S.G., Touloumis A., Collins VP, Marioni JC, et al. Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics. Proc Natl Acad Sci USA 2013; 110: 4009-14.
16. Ward J, King J. Mathematical modelling of avascular-tumour growth II: modelling growth saturation. Math Med Biol 1999; 16: 171-211.
17. Roose T, Chapman S, Maini P. Mathematical models of avascular tumor growth. SIAM Rev 2007; 49: 179-208.
18. Anderson A, Chaplain M. Continuous and discrete mathematical models of tumor-induced angiogenesis. Bull Math Biol 1998; 60: 857-99.
19. Bauer AL, Jackson TL, Jiang Y. A cell-based model exhibiting branching and anastomosis during tumor-induced angiogenesis. Biophys J 2007; 92: 3105-21.
20. Macklin P, Lowengrub JS A new ghost cell/level set method for moving boundary problems: application to tumor growth. J Sci Comput 2008; 35: 266-99.
21. Perfahl H, Byrne HM, Chen T, Estrella V., Alarcon T, Lapin A, et al Multiscale modelling of vascular tumour growth in 3D: the roles of domain size and boundary conditions. PLoS ONE 2011; 6: e14790.
22. Anderson A. A hybrid mathematical model of solid tumour invasion: the importance of cell adhesion. Math Med Biol 2005; 22: 163.
23. Frieboes HB, Zheng X, Sun C-H, Tromberg B, Gatenby R., Cristini V. An integrated computational/experimental model of tumor invasion. Cancer Res 2006; 66: 1597-604.
24. Newton PK, Mason J, Bethel K., Bazhenova L, Nieva J, Norton L., et al. Spreaders and sponges define metastasis in lung cancer: a Markov chain Monte Carlo mathematical model. Cancer Res 2013; 73: 2760-9.
25. Scott JG, Gerlee P, Basanta D., Fletcher AG, Maini PK, Anderson AR. Mathematical Modeling of the Metastatic Process, In Experimental Metastasis: Modeling and Analysis, ed. A. Malek (2013) Springer: New York, Chapter 9, 189-208.
26. Byrne H, Alarcon T, Owen M., Webb S, Maini P. Modelling aspects of cancer dynamics: a review. Philos Trans R Soc A Math Phys Eng Sci 2006; 364: 1563-78.
27. Rejniak KA, Anderson AR Hybrid models of tumor growth. Wiley Inter-discip Rev Syst Biol Med 2011; 3: 115-25.
28. Gatenby R, Gawlinski E, Gmitro A., Kaylor B, Gillies R. Acid-mediated tumor invasion: a multidisciplinary study. Cancer Res 2006; 66: 5216.
29. Gerlee P, Anderson AR A hybrid cellular automaton model of clonal evolution in cancer: the emergence of the glycolytic phenotype. J Theor Biol 2008; 250: 705-22.
30. Swanton C. Intratumor heterogeneity: evolution through space and time. Cancer Res 2012; 72: 4875-82.
31. Anderson A, Basanta D, Gerlee P., Rejniak KA. Evolution, regulation, and disruption of homeostasis, and its role incarcinogenesis. Multiscale Cancer Model 2011; 1-30.
32. Robey IF, Baggett BK, Kirkpatrick N.D., Roe DJ, Dosescu J, Sloane BF, et al Bicarbonate increases tumor pH and inhibits spontaneous metastases. Cancer Res 2009; 69: 2260-8.
33. Ibrahim-Hashim A., Cornnell HH, Abrahams D, Lloyd M., Bui M, Gillies RJ, et al Systemic buffers inhibit carcinogenesis in TRAMP mice. J Urol 2012; 188: 624-31.
34. Rapisarda A, Melillo G. Overcoming disappointing results with antiangiogenic therapy by targeting hypoxia. Nat Rev Clin Oncol 2012; 9: 378-90.
35. DiGiulio S. ASCO13: what building bridges means for oncology. Oncol Times 2013; 35: 10-4.
36. Montero AJ, Escobar M, Lopes G., Glück S, Vogel C. Bevacizumab in the treatment of metastatic breast cancer: friend or foe? Curr Oncol Rep 2012; 14: 1-11.
37. Bernards R, Weinberg RA Metastasis genes: a progression puzzle. Nature 2002; 418: 823.
38. Basanta D, Simon M, Hatzikirou H., Deutsch A. Evolutionary game theory elucidates the role of glycolysis in glioma progression and invasion. Cell Prolif 2008; 41: 980-7.
39. Aktipis CA, Maley CC, Pepper JW Dispersal evolution in neoplasms: the role of disregulated metabolism in the evolution of cell motility. Cancer Prev Res 2012; 5: 266-75.
40. Patel A, Gawlinski E, Lemieux S., Gatenby R. A cellular automaton model of early tumor growth and invasion: the effects of native tissue vascularity and increased anaerobic tumor metabolism. J Theor Biol 2001; 213: 315-31.
41. Secomb TW, Alberding JP, Hsu R, Dewhirst M.W., Pries AR. Angiogenesis: an adaptive dynamic biological patterning problem. PLoS Comput Biol 2013; 9: e1002983.
42. Misell LM, Hwang ES, Au A, Esserman L., Hellerstein MK. Development of a novel method for measuring in vivo breast epithelial cell proliferation in humans. Breast Cancer Res Treat 2005; 89: 257-64.
43. Nichols M, Foster T. Oxygen diffusion and reaction kinetics in the photodynamic therapy of multicell tumour spheroids. Phys Med Biol 1994; 39:2161-81.
44. Groebe K, Erz S, Mueller-Klieser W. Glucose diffusion coefficients determined from concentration profiles in EMT6 tumor spheroids incubated in radioactively labeled L-glucose. Adv Exp Med Biol 1994; 361: 619.
45. Vaupel P, Kallinowski F, Okunieff P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res 1989; 49: 6449-65.
46. Zierler K. Whole body glucose metabolism. Am J Physiol-Endocrinol Metabol 1999; 276: e409-E426.
47. Casciari J, Sotirchos S, Sutherland R. Variations in tumor cell growth rates and metabolism with oxygen concentration, glucose concentration, and extracellular pH. J Cell Physiol 1992; 151: 386-94.
48. Park H, Lyons J, Ohtsubo T., Song C. Acidic environment causes apoptosis by increasing caspase activity. Br J Cancer 1999; 80: 1892.
49. Kallinowski F, Vaupel P, Runkel S., Berg G, Fortmeyer H, Baessler K., et al. Glucose uptake, lactate release, ketone body turnover, metabolic micromilieu, and pH distributions in human breast cancer xenografts in nude rats. Cancer Res 1988; 48 (24 Pt 1): 7264-72.
50. Dewhirst MW, Tso C, Oliver R., Gustafson CS, Secomb TW, Gross JF. Morphologic and hemodynamic comparison oftumorandhealing normal tissue microvasculature. Int J Radiat Oncol Biol Phys 1989; 17: 91-9.